½ÃÀ庸°í¼­
»óǰÄÚµå
1628781

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Asia Pacific Healthcare Analytics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 19.23%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Asia Pacific Healthcare Analytics-Market-IMG1

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

  • IT ÇコÄÉ¾î ºÐ¾ßÀÇ ºÎ»óÀ¸·Î ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀåÀº ±Þ°ÝÇÑ ¼ºÀåÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º´Â ½Ã°è¿­ µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ¹Ì·¡ Ãß¼¼¸¦ ¿¹ÃøÇϰí, ¼º°ú¸¦ ÃøÁ¤Çϰí, ÀÇ»ç°áÁ¤À» Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ Á¤È®¼º, È¿À²¼º ¹× ¼­ºñ½º Á¦°øÀ» ÃËÁøÇÏ¿© ȯÀÚ Ä¡·á¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù.
  • ÇコÄÉ¾î ºÐ¾ß´Â ÀϹÝÀûÀ¸·Î ȯÀÚ Ä¡·á °³¼±ÀÇ Çʿ伺, Ä¡·áºñ »ó½Â, ȯÀÚ À¯ÁöÀ² °¨¼Ò µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±× °á°ú, ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º´Â ȯÀÚ¿¡°Ô ´õ ³ªÀº Ä¡·á¸¦ Á¦°øÇÏ°í ¾÷°è ¿î¿µÀ» °³¼±Çϱâ À§ÇØ ¸ðµç ºÎ¹®¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º »ê¾÷ÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
  • ÇコÄɾ ºòµ¥ÀÌÅÍ ºÐ¼®À» µµÀÔÇÔÀ¸·Î½á ºñ¿ë È¿À²ÀûÀÎ ¾à¹° Ä¡·á, Áý´Ü °Ç°­ º¸Çè °èȹ, ´õ ³ªÀº Áø´Ü Á¢±Ù¹ýÀÌ ½ÇÇöµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â °í°´ ¼ö Áõ°¡¿Í ÇÔ²² ÀÌ ºÐ¾ß¿¡ ´ëÇÑ ´õ ³ªÀº ÅõÀÚ·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
  • ¾Èº¸ ¹®Á¦, ±â¼ú ¹× ¹®È­Àû À庮, ´ÜÆíÀûÀÎ ±¹Á¦ Á¤Ä¡ °ü°è·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÐ¾ß¿¡¼­ À¯ÅëµÇ´Â Á¤º¸ÀÇ ´ëºÎºÐÀÌ ºñ°ø°³¶ó´Â Á¡µµ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
  • COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ °ø°ø ÀÇ·á ¸ð´ÏÅ͸µ°ú Áúº´ ÃßÀûÀ» À§ÇÑ ºòµ¥ÀÌÅÍ ºÐ¼®ÀÇ È°¿ëµµ°¡ ³ô¾ÆÁ³½À´Ï´Ù. ±× °á°ú, ÀÇ·á »ê¾÷ÀÇ È¯ÀÚ ºÎ´ãÀ» ó¸®Çϱâ À§ÇÑ µðÁöÅÐ ¼Ö·ç¼Ç°ú °³¼±µÈ ºÐ¼® µµ±¸¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ºÐ¾ß´Â Å« ȣȲÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ´ëÀ¯Çà ±â°£ µ¿¾È ¼öÁýµÈ ´ë·®ÀÇ ÀÓ»ó µ¥ÀÌÅÍ´Â ÀûÀýÇÑ °ü¸®°¡ ÇÊ¿äÇϸç, ¿¬±¸¿Í Àü¹®°¡µéÀº ºÐ¼® µµ±¸¿Í Ç÷§ÆûÀ» »ç¿ëÇÏ¿© ´õ ³ªÀº °á°ú¸¦ µµÃâÇϰí, Ãß¼¼¸¦ ¿¹ÃøÇϰí, Áúº´ ÀüÆÄÀÇ ¿ªÇÐÀ» ´õ Àß ºÐ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå µ¿Çâ

IT ºÐ¾ß È®´ë¿Í ÀÇ·á ¼­ºñ½º Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÀåÀ» ÁÖµµ

  • °í·ÉÈ­¿Í ¸¸¼ºÁúȯÀÇ Àå±âÈ­·Î ÀÎÇÑ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù. º´¿ø °ü¸®ÀÚµéÀº ȯÀÚ Ä¡·á ¼öÁØÀ» Áö¼ÓÀûÀ¸·Î Çâ»ó½ÃŰ¸é¼­ ºñ¿ëÀ» Àý°¨ÇØ¾ß ÇÑ´Ù´Â ¾Ð¹ÚÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯°æ¿¡¼­ º´¿øÀº º¸´Ù È¿À²ÀûÀÎ ¿î¿µ°ú ȯÀÚ Ä¡·á¸¦ Áö¿øÇϰí ȯÀÚ °æÇèÀ» °³¼±Çϱâ À§ÇØ Ãֽбâ¼ú°ú ºÐ¼®¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
  • ¼ÒºñÀÚÀÇ °Ç°­ ÁöÇ⼺ Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ Áõ°¡´Â ÀÓ»ó ¾÷¹«ÀÇ È¿À²¼º°ú ¹æ´ëÇÑ ÀÇ·á µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ Å¬¶ó¿ìµå ºÐ¼®ÀÇ µµÀÔÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ¿ìÈ£ÀûÀÎ ÇコÄɾî Á¤Ã¥µµ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
  • ¿¹¸¦ µé¾î, ÀϺ»Àº 1³â ÀÌ»ó ÀüºÎÅÍ ±¹¹Î°ú Áֹε鿡°Ô Àú·ÅÇÑ °¡°ÝÀ¸·Î ´õ ³ªÀº ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ Àü±¹¹Î ÀǷẸÇèÁ¦µµ¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. À̸¦ À§ÇØ ÀϺ»¿¡¼­´Â ÇコÄÉ¾î ¾Ö³Î¸®Æ½½ºÀÇ µµÀÔÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ Àεµ ÀÇ·á´Â Á¤º¸±â¼úÀÌ µµÀԵǾî 1Â÷ º´¿ø°ú 2Â÷ º´¿øÀÌ ÃÊÆ¯±Þº´¿ø¿¡ °øµ¿À¸·Î Á¢±ÙÇÒ ¼ö ÀÖ´Â Áß°³ÀÚ°¡ Á¸ÀçÇÏÁö ¾Ê½À´Ï´Ù. »õ·Î¿î Á¶Á÷ ¸ðµ¨Àº Áß°£ °èÃþÀ» ¾ø¾Ö°í ÀÏÂ÷ º´¿øÀÌ ÃÊÀü¹® º´¿ø°ú °øÁ¸ÇÒ ¼ö ÀÖ´Â ºÐÀ§±â¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ´Â ¾çÃø ¸ðµÎ¿¡°Ô ÀÌÀÍÀÌ µÇ´Â »óȲÀÔ´Ï´Ù.
  • ÀÇ·á IT¿¡ ´ëÇÑ ÀÇ·á ¼ÒºñÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ »çÀÌ¿¡¼­ ÀÇ·á IT¿¡ ´ëÇÑ ½Å·Ú°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ±â¹Ð µ¥ÀÌÅ͸¦ ¼Õ»ó½ÃŰÁö ¾Ê°í ¾ÈÀüÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÇコÄÉ¾î ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ¾ÖÇø®ÄÉÀ̼ǰú ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼Òºñ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Áß±¹°ú Àεµ°¡ ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷Áö

  • Áß±¹°ú Àεµ´Â ÇコÄɾî IT ¼Ö·ç¼Ç µµÀÔ°ú ¿ì¼öÇÑ IT ±â¼ú °³¹ß·Î ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Áß±¹¿¡¼­´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ÀÎÅÍ³Ý »ç¿ë°ú ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÇコÄÉ¾î ºÎÁ¤ÇàÀ§ ºÐ¼® ¹× ŽÁö ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå¿¡¼­ Áß±¹ÀÌ ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ´Â ¹Ý¸é, Àεµ´Â ¿¹Ãø ±â°£ µ¿¾È ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Àεµ¿¡¼­´Â COVID-19ÀÇ È®»êÀ¸·Î ÀÎÇØ ÀÇ·á ºÎ¹®ÀÌ ºü¸£°Ô ¹ßÀüÇÏ¿© ¼ÒºñÀÚÀÇ ÀÇ·á ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ºü¸£°Ô ¹ßÀüÇß½À´Ï´Ù. Åõ¸íÇϰí È¿À²ÀûÀÎ ÀÇ·á ºÎ¹® Á¶Á÷À» Á¦°øÇϱâ À§ÇØ ½Ã¹ÎÀÇ ÀÇ·á µ¥ÀÌÅ͸¦ µðÁöÅÐÈ­ÇÏ·Á´Â Á¤ºÎÀÇ ³ë·ÂÀÌ ÀÖ¾ú°í, ÀÌ´Â ÀεµÀÇ ÀÇ·á ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇß½À´Ï´Ù.
  • °¨¿°º´ÀÇ Áõ°¡·Î Áß±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á º¸Çè »ç±â »ç°ÇÀÌ Áõ°¡Çϸ鼭 Áß±¹ ³» ÀÇ·á »ç±â ºÐ¼® ¹× ŽÁö ½ÃÀåµµ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ßÀÇ ÀÎÇÁ¶ó °³¹ß ¹× Á¦¾àȸ»çµéÀÇ »õ·Î¿î ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º¿¡ ´ëÇÑ ÁýÁßÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
  • ¿¹¸¦ µé¾î, Áö³­ÇØ 6¿ù Áß±¹ µ¿ºÎ º¹°Ç¼º »þ¸Õ½Ã´Â ½º¸¶Æ® ÀÇ·á ¹× °Ç°­ ÁõÁø ³ë·ÂÀÇ ÀÏȯÀ¸·Î 5G ±â¹Ý ¾È°ú Áúȯ ¿ø°ÝÀÇ·á Ç÷§ÆûÀ» °³¹ßÇß½À´Ï´Ù. ÀÌ Ç÷§ÆûÀº »þ¸Õ´ëÇÐ »þ¸Õ ¾È°ú¼¾ÅÍ, Â÷À̳ªÅÚ·¹ÄÞÀÇ »þ¸Õ »ç¾÷ºÎ, È­¿þÀ̰¡ °øµ¿À¸·Î ¼³¸³ÇÑ 5G ±â¹Ý ¾È°úº´¿ø¿¡ ÀÇÇØ ±¸ÃàµÇ¸ç, 5G ±â¼úÀ» ±â¹ÝÀ¸·Î ÇÑ ¿ø°ÝÀÇ·á Ç÷§ÆûÀº ½Ç½Ã°£À¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â ÀÇ·á ¿µ»ó°ú ºñµð¿À¸¦ º¸À¯ÇÏ°Ô µË´Ï´Ù. À̸¦ ÅëÇØ ÀÇ»ç´Â ¿ø°ÝÁø·á, ¾È°ú Áúȯ¿¡ ´ëÇÑ AI °Ë»ç, ±âŸ Áø´Ü ¹× Ä¡·á ¹æ¹ý µîÀ» ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ Áö³­ÇØ 7¿ù¿¡´Â ¾Æ½ºÅ¸µð¿¥ÇコÄɾî±×·ìÀÇ Çõ½Å ÇãºêÀÎ ¾Æ½ºÅ¸ À̳뺣ÀÌ¼Ç & ¸®¼­ ¼¾ÅͰ¡ ÀÎÅÚ ¹× AI Ç÷§Æû Á¦°ø ¾÷üÀÎ CARPL.ai¿Í ÇÔ²² AI¸¦ Ȱ¿ëÇÑ °Ç°­ µ¥ÀÌÅÍ AI¸¦ Ȱ¿ëÇÑ °Ç°­ µ¥ÀÌÅÍ Ç÷§ÆûÀ» Àεµ¿¡ ±¸ÃàÇÏ¿© ·±ÄªÇÏ¿´½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º »ê¾÷ °³¿ä

IBM Corporation, SAS Institute, Oracle Corporation, Siemens Healthineers¿Í °°Àº ÁÖ¿ä ±â¾÷µéÀº ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå¿¡ »õ·Î¿î µ¿ÇâÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Siemens HealthineersÀÇ Varian Medical System, Inc.ÀÇ Àμö´Â ¿¹Ãø ±â°£ µ¿¾È ÀÌ ±â¾÷ ºÎ¹®¿¡ À¯¸ÁÇÑ Àü¸ÁÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù SAS´Â ³¶Æ® ´ëÇк´¿ø ¼¾ÅÍ(Nantes University Hospital Center)°¡ À繫, Àλç, ÀÇ·á Á¤º¸¸¦ ÅëÇÕÇÏ¿© ÀÔ¿ø ´ç ºñ¿ë¿¡ ´ëÇÑ ³»ºÎ ºÐ¼®À» ¼öÇàÇϱâ À§ÇÑ ´ë±Ô¸ð ÇÁ·ÎÁ§Æ®ÀÇ ÀÏȯÀ¸·Î µ¥ÀÌÅÍ ½Ã°¢È­¸¦ Ȱ¿ëÇϵµ·Ï Áö¿øÇß½À´Ï´Ù.

2023³â 1¿ù, ÈÄÁöÂê¿Í »ñÆ÷·Î Àǰú´ëÇÐÀº 2023³â 4¿ùºÎÅÍ ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°ú °³ÀÎ ÀÇ·á ±â·ÏÀ» Æ÷ÇÔÇÑ È¯ÀÚ ÀÇ·á µ¥ÀÌÅÍÀÇ µ¥ÀÌÅÍ À̵¿¼ºÀ» ½ÇÇöÇϱâ À§ÇÑ Çù¾÷À» ½ÃÀÛÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

±âŸ ÇýÅÃ:

  • ¿¢¼¿ Çü½ÄÀÇ ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® Áö¿ø

¸ñÂ÷

Á¦1Àå ¼Ò°³

  • Á¶»ç °¡Á¤°ú ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå °³¿ä
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ±â¼úÀÇ Áøº¸¿Í Á¤ºÎ¿¡ ÀÇÇÑ Àû±ØÀûÀÎ ´ëó
    • ÇコÄÉ¾î ¾÷°èÀÇ ºòµ¥ÀÌÅÍÀÇ ÃâÇö
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ÒÇÁÆ®¿þ¾î ºñ¿ë°ú º¹À⼺
    • µ¥ÀÌÅÍ ¿ÏÀü¼º°ú ÇÁ¶óÀ̹ö½Ã¿¡ °üÇÑ ¿ì·Á
    • ÀûÀýÇÑ ¼÷·Ã ³ëµ¿ÀÚÀÇ ºÎÁ·
  • ¹ë·ùüÀÎ/°ø±Þ¸Á ºÐ¼®
  • Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °­µµ

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

  • Àü°³º°
    • ¿ÂÇÁ·¹¹Ì½º
    • Ŭ¶ó¿ìµå
  • ¿ëµµº°
    • ÀÓ»ó µ¥ÀÌÅÍ ºÐ¼®
    • À繫 µ¥ÀÌÅÍ ºÐ¼®
    • ¿î¿µ/°ü¸® µ¥ÀÌÅÍ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚº°
    • ÀÇ·á Á¦°øÀÚ
    • Á¦¾à ¾÷°è
    • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö »ê¾÷
    • Çмú±â°ü
  • ±¹°¡º°
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦6Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • SAS Institute Inc.
    • Optum, Inc.
    • Cerner Corporation
    • Health Catalyst
    • McKesson Corporation
    • Wipro Limited
    • Inovalon
    • IQIVA Inc.

Á¦7Àå ÅõÀÚ ºÐ¼®

Á¦8Àå ½ÃÀå Àü¸Á

ksm 25.01.17

The Asia Pacific Healthcare Analytics Market is expected to register a CAGR of 19.23% during the forecast period.

Asia Pacific Healthcare Analytics - Market - IMG1

Key Highlights

  • There has been exponential growth in the healthcare analytics market due to the rise of the IT healthcare sector. Healthcare analytics can predict future trends, measure performance, and evaluate decisions using chronological data. This will help improve patient care by advancing accuracy, efficiency, and service delivery.
  • The healthcare sector, in general, has been faced with challenges such as the need for improved patient care, rising treatment costs, and decreased patient retention. Consequently, healthcare analytics are getting integrated into every sector to provide better treatment to patients and improve industry operations. These are significant factors driving the expansion of the healthcare analytics industry.
  • They are adopting big data analytics in healthcare, resulting in cost-effective medication, insurance planning concerning population health, and better diagnostic approaches. Because of this, there is an increase in the number of customers, leading to better investments in the sector.
  • Security issues, technological and cultural barriers, and fragmented international political relations hinder the market's growth. The growth of the market is also slowed by the fact that most of the information sent in this sector is private.
  • The COVID-19 outbreak increased the use of big data analytics for public healthcare surveillance and disease tracking. As a result, the sector in this region witnessed a significant boom owing to a rise in the necessity for digital solutions and improved analytics tools to handle the patient burden on the healthcare industry. The volume of clinical data collected during the pandemic required adequate management, and researchers and experts could extract better outcomes, forecast trends, and analyze disease transmission dynamics much better by using analytics tools and platforms.

Asia Pacific Healthcare Analytics Market Trends

Expanding IT sector and demand for improved medical services to drive the market

  • The growing demand for remote patient monitoring solutions, owing to the aging population and long-term chronic disease conditions, is the primary factor impacting the growth of the market studied. There is constant pressure on hospital administrators to lower costs while continuing to improve the level of patient care. In this environment, hospitals are turning to modern technologies and analytics to operate more efficiently, support patient care, and improve patient experience. This is further driving the growth of the healthcare analytics market in Asia-Pacific.
  • The widespread growth in health consciousness among consumers and an increase in chronic diseases have led to the adoption of cloud analytics to improve the efficiency of clinical operations and manage extensive medical data. Favorable governmental healthcare policies are also driving the market.
  • For example, Japan provides universal insurance schemes and better healthcare at affordable prices to its citizens and residents for more than a year.This has increased the adoption of healthcare analytics in the country.
  • Moreover, with the advent of information technology in Indian medical care, there is no intermediary to allow primary and secondary-level hospitals joint access to super-specialty hospitals. The new organizational model removes the middle class and provides an atmosphere that helps primary-level hospitals co-exist with super-specialty hospitals. This is a mutually beneficial situation for both partners.
  • Confidence in health IT is increasing among healthcare consumers and providers. This has increased the consumption of applications and software that provide safe and reliable healthcare solutions without compromising sensitive data.

China and India to hold major shares in the market

  • China and India drive the Asia-Pacific market by adopting IT solutions for healthcare and developing better IT skills. The demand for healthcare fraud analytics and detection in China is also growing with increased internet usage and technology in the healthcare sector. India is expected to register rapid growth in the market during the forecast period, whereas China holds a majority share in the Asia Pacific healthcare analytics market.
  • Because of the spread of COVID-19 in India, the healthcare sector evolved quickly to meet the growing medical needs of consumers.There were government initiatives to digitize citizens' medical data in order to provide a transparent and efficient healthcare sector organization.This aided the growth of the healthcare analytics market in the country.
  • An increase in the growth of infectious diseases is boosting the demand for healthcare analytics in China. The healthcare fraud analytics and detection market is also growing in China due to increased cases of medical insurance fraud. The development of infrastructure in the healthcare sector and a focus on new healthcare analytics by pharmaceutical companies are fueling the market's growth.
  • For instance, in June last year, as part of its efforts to boost smart medicine and health, Xiamen, a city in east China's Fujian Province, developed a 5G-based telemedicine platform for eye diseases. The platform will be built by a 5G-powered eye hospital jointly established by Xiamen University's Xiamen Eye Center, China Telecom's Xiamen division, and Huawei. Based on 5G technology, the telemedicine platform will have medical images and videos that are updated in real time. This will let doctors do things like remote consultations, AI screening for eye diseases, and other ways to diagnose and treat patients.
  • Also, in July last year, the Aster Innovation and Research Centre, the Aster DM Healthcare Group's innovation hub, collaborated with Intel Corporation and AI platform provider CARPL.ai to create and launch an AI-powered health data platform in India.

Asia Pacific Healthcare Analytics Industry Overview

Significant players like IBM Corporation, SAS Institute, Oracle Corporation, and Siemens Healthcare are bringing new trends into the healthcare analytics market. For example, the acquisition of Varian Medical System, Inc. by Siemens Healthineers provides the company segment with a promising outlook for the forecast period. In the recent past, SAS helped Nantes University Hospital Center use data visualization as part of a larger project to integrate financial affairs, human resources, and medical information and produce an in-house analysis of the costs per hospitalization.

In January 2023, Fujitsu and Sapporo Medical University announced the launch of a cooperative effort to achieve data portability for patients' healthcare data, including electronic health records (EHRs) and personal health records, beginning in April 2023.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements and Favorable Governemnt Initiatives
    • 4.2.2 Emergence of Big Data in the Healthcare Industry
  • 4.3 Market Restraints
    • 4.3.1 Cost and Complexity of Software
    • 4.3.2 Data Integrity and Privacy Concerns
    • 4.3.3 Lack of Proper Skilled Labors
  • 4.4 Value Chain / Supply Chain Analysis
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Deployment
    • 5.1.1 On-Premise
    • 5.1.2 Cloud
  • 5.2 By Application
    • 5.2.1 Clinical Data Analytics
    • 5.2.2 Financial Data Analytics
    • 5.2.3 Operational/Administrative Data Analytics
  • 5.3 By End-User
    • 5.3.1 Healthcare Provider
    • 5.3.2 Pharmaceutical Industry
    • 5.3.3 Biotechnology Industry
    • 5.3.4 Academic Organization
  • 5.4 By Country
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 South Korea
    • 5.4.5 Australia
    • 5.4.6 Indonesia
    • 5.4.7 Rest of Asia Pacific

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 SAS Institute Inc.
    • 6.1.2 Optum, Inc.
    • 6.1.3 Cerner Corporation
    • 6.1.4 Health Catalyst
    • 6.1.5 McKesson Corporation
    • 6.1.6 Wipro Limited
    • 6.1.7 Inovalon
    • 6.1.8 IQIVA Inc.

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦